Stay updated on Nivolumab in IDH-Mutant Gliomas Clinical Trial
Sign up to get notified when there's something new on the Nivolumab in IDH-Mutant Gliomas Clinical Trial page.

Latest updates to the Nivolumab in IDH-Mutant Gliomas Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check19 days agoChange DetectedThe page's revision tag was updated from v3.6.2 to v3.6.3. This indicates a minor platform update that does not alter the displayed study details.SummaryDifference0.1%

- Check26 days agoChange DetectedRevision updated to v3.6.2, indicating a minor template/renderer update applied to the study page. This change does not modify the study content or data fields.SummaryDifference0.1%

- Check40 days agoChange DetectedThe page now shows 'No longer looking for participants,' signaling that enrollment is closed, and it also adds user guidance sections such as How to Read a Study Record, Common Questions, and How to Join a Study, along with a formatting tweak to the Intervention/Treatment header and a revision version update.SummaryDifference0.4%

- Check47 days agoChange DetectedRevision label updated from v3.5.4 to v3.5.5, signaling a small software update to the page’s framework. This change does not modify the study content or user-facing data.SummaryDifference0.1%

- Check68 days agoChange DetectedThe page now displays Revision: v3.5.4, replacing Revision: v3.5.3 to reflect a newer, minor update to the page's documentation/version history.SummaryDifference0.1%

- Check90 days agoChange DetectedThe page footer “Revision” number was updated from v3.5.0 to v3.5.3, indicating a website software/version change rather than a change to the clinical trial information.SummaryDifference0.1%

Stay in the know with updates to Nivolumab in IDH-Mutant Gliomas Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab in IDH-Mutant Gliomas Clinical Trial page.